Live Attenuated Necator Americanus Larvae Vaccine Shows Promise In Phase 1 Trial

October 20, 2021

Infectious Disease Advisor (10/19, Gupta) reports research indicates that “a live attenuated human hookworm vaccine was well tolerated and elicited humoral and cellular immune responses to hookworm antigens.” The “phase 1 study conducted in Australia was...